Company: BDRX
Filing Date: 2025-05-08
Form Type: POS AM
Source: 0001214659-25-007201
Chunk: 12

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-08
Form: POS AM
Chunk 12
---
                                                                                                                                                                                                                                                                                                 
 Shares and the deposit agreement, including applicable fees and charges, you should carefully read “Description of American Depositary                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
 Shares” in this prospectus. You should also read the deposit agreement, which is an exhibit to the registration statement that                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
 includes this prospectus.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Depositary                                                              |     | JPMorgan Chase Bank, N.A.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Use of proceeds                                                         |     | We will not receive any proceeds from the sale of the Ordinary Shares represented by Depositary Shares by the selling shareholders. All net proceeds from the sale of the Ordinary Shares represented by Depositary Shares covered by this prospectus will go to the selling shareholders. However, we will receive the proceeds from any exercise of the warrants exercised for cash. See the section of this prospectus titled “Use of Proceeds.”                                                                                                                                                              |
| Risk factors                                                            |     | You should read the “Risk Factors” section starting                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
 on page 9 of this prospectus for a discussion of factors to consider before deciding to invest in our securities.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Dividend policy                                                         |     | We have never declared or paid any cash dividends to our shareholders, and we currently do not expect to declare or pay any cash dividends in the foreseeable future. See “Dividend Policy.”                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Listing                                                                 |     | Our Depositary Shares are listed on the NASDAQ Capital Market under the symbol “BDRX.”                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |

| 8 |

<div align='center'>RISK FACTORS</div>

Our business has significant risks. In addition to the other information included in this annual report, including the matters addressed in the section of the annual report entitled “Cautionary Note Regarding Forward-Looking Statements” and in our financial statements and the related notes, you should consider carefully the risks described below. The risks and uncertainties described below are not the only risks and uncertainties we may face. Additional risks and uncertainties not presently known to us, or that we currently consider immaterial could also negatively affect our business, financial condition, results of operations, prospects, profits and stock prices. If any of the risks described below actually occur, our business, financial condition, results of operations, prospects, profits and stock prices could be materially adversely affected.

The sale of a substantial amount of our Ordinary Shares (represented by Depositary Shares), including resale of the Ordinary Shares (represented by Depositary Shares) iss